Kyle Wood
Urology · Birmingham, ALNPI 1942595350
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $59,436 of the $90,981 with a category attached, or 65.3%. Alnylam Pharmaceuticals Inc. accounts for 82.0% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $24,181 and has fallen 59.5% since, to $9,801 in 2025. Among urology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $957.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$75K
- Novo Nordisk Health Care AG$7K
- Novo Nordisk$3K
- Mirum Pharmaceuticals, Inc.$2K
- Biomarin Pharmaceutical Inc.$1K
- Boston Scientific$1K
- plus $2K from 11 others
Across 15 payments — averaging $8382.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alnylam Pharmaceuticals Inc.$63K
- Calyxo, Inc.$62K
- Steris Instrument Management Services, Inc.$707
What the payments were for
- Consulting fees$59,43665%
- Speaking & faculty fees$19,28221%
- Travel & lodging$8,96410%
- Food & beverage$3,2214%
- Education$10%
- Gifts$770%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 54 | $74,580 |
| Novo Nordisk Health Care AG | 3 | $7,156 |
| Novo Nordisk | 9 | $3,108 |
| Mirum Pharmaceuticals, Inc. | 1 | $1,950 |
| Biomarin Pharmaceutical Inc. | 1 | $1,450 |
| Boston Scientific | 6 | $1,171 |
| Calyxo, Inc. | 8 | $905 |
| Olympus America Inc. | 1 | $136 |
| Cook Medical LLC | 1 | $135 |
| KARL Storz Endoscopy-america | 1 | $87 |
| Tosoh Bioscience, Inc. | 1 | $77 |
| Cycle Pharmaceuticals Inc | 3 | $57 |
| Myriad Genetic Laboratories, Inc. | 1 | $50 |
| Procept Biorobotics Corporation | 1 | $47 |
| Steris Corporation | 2 | $44 |
| Axonics, Inc. | 1 | $28 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OXLUMO$51,150
- ONPATTRO$4,120
- CVAC Aspiration System$744
- GENERAL KIDNEY STONE DISEASE$675
- Rivfloza$219
- Moses 550 D\F\L$136
- URETERO-RENO VIDEOSCOPE$136
- UroPass$136
- Cook$135
- Lumenis Pulse 120H$126
- LITHOCLAST$125
- Tria Firm$110
How this compares
$90,981 in reported general payments places this provider in the 95th percentile of 179 urology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ThiolaTiopronin | 12 | $124,675 |
| Thiola EcTiopronin | 11 | $83,418 |
| MyrbetriqMirabegron | 32 | $16,043 |
| Potassium Citrate ErPotassium Citrate | 51 | $4,448 |
| Tamsulosin Hcl | 144 | $1,179 |
| Finasteride | 39 | $524 |
| Cefpodoxime Proxetil | 13 | $330 |
| Solifenacin Succinate | 11 | $290 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $178 |
| Oxybutynin Chloride ErOxybutynin Chloride | 17 | $139 |
| Ciprofloxacin Hcl | 30 | $103 |
| Ondansetron Hcl | 15 | $92 |
| Cephalexin | 12 | $92 |
| Oxycodone Hcl | 36 | $50 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $48 |
Paid to pharmacies, not to this prescriber.
Other urology in Birmingham
- Thomas ChiBirmingham$463K
- Joel FunkBirmingham$347K
- Adam BaumgartenBirmingham$271K
- Jeffrey NixBirmingham$54K
- Tracey WilsonBirmingham$38K
- Charles PeytonBirmingham$27K
- Kazumi TaguchiBirmingham$19K
- Andrew FangBirmingham$5K
- Kyle GennaroBirmingham$5K
- Brian ChristineHomewood$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.